ITC starts clinical trials for nasal spray to prevent Covid-19 infection

Sources say product is being steered by ITC Life Sciences and Technology Centre; Bengaluru. Internal trials found it to be effective against other viruses like common cold. Trials could take 3 months

Diversified conglomerate, ITC, is developing a nasal spray for Covid-19 prevention for which it has initiated clinical trials.

An ITC spokesperson confirmed the development but said, “We are unable to share more details at the current moment as the clinical trials are underway.”

However, sources indicated that the product was being steered by the ITC Life Sciences and Technology Centre (LSTC) in Bangalore and it had the potential to be effective in preventing infection as well as transmission of Covid-19. Internal trials had also found it to be effective against other viruses like common cold.

The trials could take about